Alamar Blue assay optimization to minimize drug interference and inter assay viability

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Alamar Blue (AB) is a popular, cost-effective, and nondestructive reagent for cell viability assays.
• Previous studies have noted discrepancies in dose-response curves when using AB compared to other assays like Cell-Titer Glo, particularly with EGFR inhibitors.
• Investigating osimertinib's effect on non-small cell lung cancer (NSCLC) cell line PC-9 revealed unexpected right-shifts in AB assay dose-response curves.

Purpose of the Study:

• To describe a modified Alamar Blue assay method to overcome assay interference and achieve accurate dose-response curves.
• To optimize Alamar Blue assay protocols for enhanced reliability in cell viability and drug response studies.
• To establish Alamar Blue as a suitable method for longitudinal monitoring of cell growth and drug toxicity recovery.

Main Methods:

• The modified method involves the removal of drug-containing medium before Alamar Blue addition to prevent interference.
• Plate-to-plate variability was minimized by incorporating a fluorescence calibration standard for fluorimeter sensitivity adjustment.
• The modified assay was validated by comparing dose-response curves with those obtained from the Cell Titer Glo assay.

Main Results:

• Removal of the drug-containing medium successfully eliminated falsely elevated readings, yielding dose-response curves comparable to the Cell Titer Glo assay.
• The addition of a fluorescence calibration standard effectively minimized plate-to-plate variability, ensuring consistent assay sensitivity.
• The modified Alamar Blue assay demonstrated comparable accuracy to Cell Titer Glo for evaluating drug effects on cancer cell lines.

Conclusions:

• The modified Alamar Blue assay provides accurate and reliable cell viability data, comparable to established methods like Cell Titer Glo.
• This optimized protocol addresses previous limitations, making Alamar Blue a robust tool for cancer drug efficacy studies.
• The Alamar Blue assay can be utilized for continuous, longitudinal monitoring of cell health and recovery from cytotoxic treatments.